Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
Condition(s):Advanced NSCLC; Circulating Tumor Cells; Circulating Tumor DNALast Updated:January 18, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Advanced NSCLC; Circulating Tumor Cells; Circulating Tumor DNALast Updated:January 18, 2020Unknown status
Condition(s):Advanced Lung Non-Small Cell CarcinomaLast Updated:January 23, 2024Recruiting
Condition(s):NSCLC; EGFR Gene MutationLast Updated:October 23, 2023Recruiting
Condition(s):EGFR/ ALK-negative Advanced NSCLCLast Updated:February 15, 2024Enrolling by invitation
Condition(s):Non Small Cell Lung CancerLast Updated:August 28, 2019Completed
Condition(s):Advanced NSCLCLast Updated:October 27, 2022Not yet recruiting
Condition(s):Locally Advanced NSCLCLast Updated:April 5, 2023Enrolling by invitation
Condition(s):Stage III Non-small-cell Lung Cancer; Stage IV Non-small Cell Lung Cancer; Radiotherapy Side EffectLast Updated:September 11, 2023Recruiting
Condition(s):Lung Cancer; Non Small Cell Lung CancerLast Updated:March 12, 2024Recruiting
Condition(s):Unresectable Locally Advanced NSCLCLast Updated:October 30, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.